Search Back New search Go to resultsDiseaseMain groupHematological Diseases, Non-MalignantProtocol groupAnemias, CytopeniasDiseaseSevere Aplastic AnemiaSubgroupICD10D61.-MeSHAnemia, AplasticSequenceChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceAciclovirAnti-thymocyte Globulin (Equine)Balanced Crystalloid SolutionCiclosporin ACiprofloxacinDimetindenEltrombopagParacetamolPosaconazolePrednisoloneSupportive substanceAciclovirAnti-thymocyte Globulin (Equine)Balanced Crystalloid SolutionCiclosporin ACiprofloxacinDimetindenEltrombopagParacetamolPosaconazolePrednisoloneSupportive substanceAciclovirAnti-thymocyte Globulin (Equine)Balanced Crystalloid SolutionCiclosporin ACiprofloxacinDimetindenEltrombopagParacetamolPosaconazolePrednisoloneSupportive substanceAciclovirAnti-thymocyte Globulin (Equine)Balanced Crystalloid SolutionCiclosporin ACiprofloxacinDimetindenEltrombopagParacetamolPosaconazolePrednisoloneNo. Substances910Protocol classificationTherapy classificationcurrent standardIntensityStandard doseTherapy indicationFirst lineTherapy phaseTherapy intentioncurativeRisksFebrile NeutropeniaHepatotoxicityPainPneumoniaRashSerum SicknessThrombocytopenia below 50 000/µlUpper Respiratory Tract Infection only studiesPublicationAuthorScheinberg PTownsley DMDiseaseschwere aplastische Anämie, Alter > 2 Jahre schwere aplastische Anämie, Alter > 12 Jahre OriginClinical Center - all at the National Institutes of Health, BethesdaHematology Branch and Office of Biostatistics Research, National Heart, Lung, and Blood Institute and Center for Human Immunology, Autoimmunity, and Inflammation, National Institutes of Health, BethesdaProtocols in Revision 2 protocols foundProtocols under revision.Anti-thymocyte globulin (Equine) 40 / Ciclosporin 5 / Eltrombopag 150, Severe Aplastic Anemia (PID1779)Anti-thymocyte Globulin (Equine) 40 / Ciclosporin 5, Severe Aplastic Anemia (PID908)